Trials / Completed
CompletedNCT00100295
Herbal Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
Controlled Trial of an Herbal Treatment for Juvenile Attention Deficit Hyperactivity Disorder
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- National Center for Complementary and Integrative Health (NCCIH) · NIH
- Sex
- All
- Age
- 6 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the safety and effectiveness of an herbal product for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Detailed description
ADHD is a common childhood disorder associated with concentration problems and disruptive behavior. Evidence suggests that herbal remedies may be as effective as standard drug therapies in treating ADHD symptoms. This study will determine the safety and efficacy of an herbal treatment in children and adolescents with ADHD. This study will last 9 weeks. Participants will be randomly assigned to receive either an herbal product or placebo three times a day for the duration of the study. Participants will come in for weekly study visits at which their ADHD symptoms and any side effects will be assessed by self-report rating scales.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hypericum perforatum | 300 mg capsule taken three times a day |
| OTHER | Placebo | 300 mg given three times a day, containing rice protein powder |
Timeline
- Start date
- 2005-02-01
- Completion
- 2006-11-01
- First posted
- 2004-12-29
- Last updated
- 2007-10-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00100295. Inclusion in this directory is not an endorsement.